| Frequent inactivation of A20 in B-cell lymphomas M Kato, M Sanada, I Kato, Y Sato, J Takita, K Takeuchi, A Niwa, Y Chen, ... Nature 459 (7247), 712-716, 2009 | 668 | 2009 |
| Phase I/II study of concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: Japan Clinical Oncology Group Study JCOG0211 M Yamaguchi, K Tobinai, M Oguchi, N Ishizuka, Y Kobayashi, Y Isobe, ... Journal of clinical oncology 27 (33), 5594, 2009 | 407 | 2009 |
| Maintenance treatment of patients with myelodysplastic syndromes using recombinant human granulocyte colony-stimulating factor RS Negrin, DH Haeuber, A Nagler, Y Kobayashi, J Sklar, T Donlon, ... | 305 | 1990 |
| A point mutation at codon 13 of the N-ras oncogene in myelodysplastic syndrome H Hirai, Y Kobayashi, H Mano, K Hagiwara, Y Maru, M Omine, ... Nature 327 (6121), 430-432, 1987 | 289 | 1987 |
| Feasibility and pharmacokinetic study of a chimeric anti-CD20 monoclonal antibody (IDEC-C2B8, rituximab) in relapsed B-cell lymphoma K Tobinai, Y Kobayashi, M Narabayashi, M Ogura, Y Kagami, ... Annals of Oncology 9 (5), 527-534, 1998 | 206 | 1998 |
| Consistent Detection of TLS/FUS-ERG Chimeric Transcripts in Acute Myeloid Leukemia With t(16; 21)(p11; q22) and Identification of a Novel Transcript XT Kong, K Ida, H Ichikawa, K Shimizu, M Ohki, N Maseki, Y Kaneko, ... Blood, The Journal of the American Society of Hematology 90 (3), 1192-1199, 1997 | 171 | 1997 |
| CD5-positive diffuse large B-cell lymphoma: a retrospective study in 337 patients treated by chemotherapy with or without rituximab K Miyazaki, M Yamaguchi, R Suzuki, Y Kobayashi, AM Maeshima, ... Annals of Oncology 22 (7), 1601-1607, 2011 | 156 | 2011 |
| Inactivation of multiple tumor-suppressor genes involved in negative regulation of the cell cycle, MTS1/p16INK4A/CDKN2, MTS2/p15INK4B, p53, and Rb genes in primary lymphoid … A Hangaishi, S Ogawa, N Imamura, S Miyawaki, Y Miura, N Uike, ... | 156 | 1996 |
| Treatments and outcomes of patients with extranodal natural killer/T-cell lymphoma diagnosed between 2000 and 2013: a cooperative study in Japan M Yamaguchi, R Suzuki, M Oguchi, N Asano, J Amaki, T Akiba, T Maeda, ... Journal of Clinical Oncology 35 (1), 32-39, 2017 | 150 | 2017 |
| Concurrent chemoradiotherapy for localized nasal natural killer/T-cell lymphoma: an updated analysis of the Japan clinical oncology group study JCOG0211 M Yamaguchi, K Tobinai, M Oguchi, N Ishizuka, Y Kobayashi, Y Isobe, ... Journal of Clinical Oncology 30 (32), 4044-4046, 2012 | 149 | 2012 |
| Factors affecting toxicity, response and progression-free survival in relapsed patients with indolent B-cell lymphoma and mantle cell lymphoma treated with rituximab: a … T Igarashi, Y Kobayashi, M Ogura, T Kinoshita, T Ohtsu, Y Sasaki, ... Annals of oncology 13 (6), 928-943, 2002 | 145 | 2002 |
| Detection of the t (14; 18) at similar frequencies in hyperplastic lymphoid tissues from American and Japanese patients. JC Aster, Y Kobayashi, M Shiota, S Mori, J Sklar The American journal of pathology 141 (2), 291, 1992 | 145 | 1992 |
| Effect of human recombinant granulocyte colony-stimulating factor on hematopoietic injury in mice induced by 5-fluorouracil M Shimamura, Y Kobayashi, A Yuo, A Urabe, T Okabe, Y Komatsu, S Itoh, ... | 139 | 1987 |
| Long-term follow-up results of no initial therapy for ocular adnexal MALT lymphoma K Tanimoto, A Kaneko, S Suzuki, N Sekiguchi, D Maruyama, SW Kim, ... Annals of Oncology 17 (1), 135-140, 2006 | 137 | 2006 |
| Treatment of myelodysplastic syndromes with recombinant human granulocyte colony-stimulating factor: a preliminary report Y Kobayashi, T Okabe, K Ozawa, S Chiba, M Hino, K Miyazono, A Urabe, ... The American journal of medicine 86 (2), 178-182, 1989 | 133 | 1989 |
| Markedly improved outcomes and acceptable toxicity in adolescents and young adults with acute lymphoblastic leukemia following treatment with a pediatric protocol: a phase II … F Hayakawa, T Sakura, T Yujiri, E Kondo, K Fujimaki, O Sasaki, ... Blood cancer journal 4 (10), e252-e252, 2014 | 128 | 2014 |
| Long-term low-dose acyclovir against varicella-zoster virus reactivation after allogeneic hematopoietic stem cell transplantation Y Kanda, S Mineishi, T Saito, A Saito, S Yamada, M Ohnishi, A Chizuka, ... Bone marrow transplantation 28 (7), 689-692, 2001 | 128 | 2001 |
| Japanese multicenter phase II and pharmacokinetic study of rituximab in relapsed or refractory patients with aggressive B-cell lymphoma K Tobinai, T Igarashi, K Itoh, Y Kobayashi, M Taniwaki, M Ogura, ... Annals of oncology 15 (5), 821-830, 2004 | 124 | 2004 |
| Pre-emptive therapy against cytomegalovirus (CMV) disease guided by CMV antigenemia assay after allogeneic hematopoietic stem cell transplantation: a single-center experience … Y Kanda, S Mineishi, T Saito, S Seo, A Saito, K Suenaga, M Ohnishi, ... Bone marrow transplantation 27 (4), 437-444, 2001 | 123 | 2001 |
| Primary bone lymphoma: a new and detailed characterization of 28 patients in a single-institution study D Maruyama, T Watanabe, Y Beppu, Y Kobayashi, SW Kim, K Tanimoto, ... Japanese journal of clinical oncology 37 (3), 216-223, 2007 | 113 | 2007 |
